Direct Tracking of Amyloid and Tau Dynamics in Neuroblastoma Cells Using Nanoplasmonic Fiber Tip Probes
Source abstract
Abstract
Amyloid plaques and neurofibrillary tangles are the pathological hallmarks of Alzheimer's disease. However, there has been a long-standing discussion on the dynamic relations between Aβ and tau proteins, partially due to the lack of a tool to track protein dynamics in individual live neurons at the early stage of Aβ generation and tau phosphorylation. Here, we developed nanoplasmonic fiber tip probe (nFTP) technology to simultaneously monitor Aβ42 generation and tau phosphorylation (at serine 262) in living, single neuroblastoma cells over 12 h. We observed that Aβ42 generation, under clinically relevant anesthetic treatment, preceded tau phosphorylation, which then facilitated Aβ42 generation. This observation is also supported by measuring proteins in cell lysates using the ultrasensitive label-free photonic crystal nanosensors. nFTP therefore provides an advanced method to investigate protein expression and post-translational modification in live cells and determine outcomes of intervention of Alzheimer's disease and other neurodegenerative disorders.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Alzheimer's disease research and treatments · Lipid Membrane Structure and Behavior · Cellular transport and secretion
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Rowland Institute at Harvard University, Cambridge, Massachusetts 02142, United States
Geriatric Anesthesia Research Unit, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, United States
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, United States
Funding
National Institutes of Health · U.S. Department of Health and Human Services
References (36)
Show source-provided references
1. 10.1126/science.107299410.1126/science.1072994 ↗
2. 10.1042/bss067019510.1042/bss0670195 ↗
3. 10.1007/978-1-60761-744-0_1310.1007/978-1-60761-744-0_13 ↗
4. 10.1016/j.neuron.2008.11.00710.1016/j.neuron.2008.11.007 ↗
5. 10.1038/nmeth81710.1038/nmeth817 ↗
6. 10.1126/science.112461810.1126/science.1124618 ↗
7. 10.1126/science.119203310.1126/science.1192033 ↗
8. 10.1126/science.143978510.1126/science.1439785 ↗
9. 10.1038/7733710.1038/77337 ↗
10. 10.1007/s00216-005-3256-710.1007/s00216-005-3256-7 ↗
11. 10.1038/nnano.2010.24110.1038/nnano.2010.241 ↗
12. 10.1038/nature0923210.1038/nature09232 ↗
13. 10.1038/nnano.2011.22610.1038/nnano.2011.226 ↗
14. 10.1021/nl304602d10.1021/nl304602d ↗
15. 10.1039/C1CS15237H10.1039/C1CS15237H ↗
16. 10.1038/nnano.2014.7310.1038/nnano.2014.73 ↗
17. 10.1038/srep0617910.1038/srep06179 ↗
18. 10.1146/annurev.biophys.37.092607.17464010.1146/annurev.biophys.37.092607.174640 ↗
19. 10.1523/JNEUROSCI.5320-06.200710.1523/JNEUROSCI.5320-06.2007 ↗
20. 10.1371/journal.pone.003938610.1371/journal.pone.0039386 ↗
21. 10.1073/pnas.060291310310.1073/pnas.0602913103 ↗
22. Hubinger G. · J. Alzheimers Dis. · 2008 · 13 · 28110.3233/JAD-2008-13306 ↗
23. 10.1063/1.342912510.1063/1.3429125 ↗
24. 10.1364/OE.19.01852910.1364/OE.19.018529 ↗
25. 10.1364/OE.21.03222510.1364/OE.21.032225 ↗
26. 10.1021/acsphotonics.5b0060210.1021/acsphotonics.5b00602 ↗
27. 10.1364/OE.21.03230610.1364/OE.21.032306 ↗
28. 10.1002/pmic.20080045410.1002/pmic.200800454 ↗
29. 10.1146/annurev.pharmtox.011008.14560610.1146/annurev.pharmtox.011008.145606 ↗
30. 10.1091/mbc.E12-09-067710.1091/mbc.E12-09-0677 ↗
31. 10.1038/nrm146810.1038/nrm1468 ↗
32. 10.1016/j.cell.2005.02.00810.1016/j.cell.2005.02.008 ↗
33. 10.1056/NEJMra090914210.1056/NEJMra0909142 ↗
34. 10.1016/j.cell.2012.02.04010.1016/j.cell.2012.02.040 ↗
35. 10.1038/nature1082110.1038/nature10821 ↗
36. 10.1038/nature1380010.1038/nature13800 ↗